A resolution by the Vietnamese Government instructed its Ministry of Health to consummate the transaction and, in coordination with local specialized agencies, to carry out the usual tests to validate the quality of the vaccine, produced by the Havana-based Center for Genetic Engineering and Biotechnology (CIGB).
Cuba also confirmed on Sunday that it will transfer to Vietnam the production technology of Abdala (CIGB-66), one of the three own vaccines used in its vaccination campaign.
Vietnam will thus become the first country outside Cuba to produce this medicine, whose emergency use was approved on Saturday.
On Sunday, also in Havana, Cuba’s Biotechnology and Pharmaceutical Industries Business Group and Vietnam’s Sovico Group sealed a memorandum of understanding to establish alliances in the field of the anti-Covid-19 immunogens and the treatment of chronic non-communicable diseases.
Cuba, the only Latin American country with three of its own anti-Covid-19 vaccines (Abdala (CIGB-66), Soberana 02, Soberana Plus), also has the vaccine candidates, Soberana 01 and Mambisa (CIGB-669). The latter is one of the few globally that is administered nasally.